Cingulate Stock Performance

CING Stock  USD 3.65  0.05  1.35%   
The firm shows a Beta (market volatility) of 1.01, which signifies a somewhat significant risk relative to the market. Cingulate returns are very sensitive to returns on the market. As the market goes up or down, Cingulate is expected to follow. At this point, Cingulate has a negative expected return of -0.0987%. Please make sure to confirm Cingulate's accumulation distribution, and the relationship between the value at risk and day typical price , to decide if Cingulate performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Cingulate has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Cingulate is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Begin Period Cash Flow5.4 M
  

Cingulate Relative Risk vs. Return Landscape

If you would invest  410.00  in Cingulate on December 19, 2024 and sell it today you would lose (41.00) from holding Cingulate or give up 10.0% of portfolio value over 90 days. Cingulate is currently does not generate positive expected returns and assumes 4.0117% risk (volatility on return distribution) over the 90 days horizon. In different words, 35% of stocks are less volatile than Cingulate, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Cingulate is expected to under-perform the market. In addition to that, the company is 4.68 times more volatile than its market benchmark. It trades about -0.02 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.03 per unit of volatility.

Cingulate Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Cingulate's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cingulate, and traders can use it to determine the average amount a Cingulate's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0246

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsCING

Estimated Market Risk

 4.01
  actual daily
35
65% of assets are more volatile

Expected Return

 -0.1
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.02
  actual daily
0
Most of other assets perform better
Based on monthly moving average Cingulate is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cingulate by adding Cingulate to a well-diversified portfolio.

Cingulate Fundamentals Growth

Cingulate Stock prices reflect investors' perceptions of the future prospects and financial health of Cingulate, and Cingulate fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cingulate Stock performance.

About Cingulate Performance

By analyzing Cingulate's fundamental ratios, stakeholders can gain valuable insights into Cingulate's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cingulate has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cingulate has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficithyperactivity disorder. The company was founded in 2012 and is headquartered in Kansas City, Kansas. Cingulate operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.

Things to note about Cingulate performance evaluation

Checking the ongoing alerts about Cingulate for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cingulate help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cingulate generated a negative expected return over the last 90 days
Cingulate has high historical volatility and very poor performance
Cingulate has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (23.53 K) with loss before overhead, payroll, taxes, and interest of (10.1 M).
Cingulate currently holds about 8.2 M in cash with (15.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73.
Cingulate has a poor financial position based on the latest SEC disclosures
Evaluating Cingulate's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Cingulate's stock performance include:
  • Analyzing Cingulate's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cingulate's stock is overvalued or undervalued compared to its peers.
  • Examining Cingulate's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Cingulate's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cingulate's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Cingulate's stock. These opinions can provide insight into Cingulate's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Cingulate's stock performance is not an exact science, and many factors can impact Cingulate's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Cingulate Stock analysis

When running Cingulate's price analysis, check to measure Cingulate's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cingulate is operating at the current time. Most of Cingulate's value examination focuses on studying past and present price action to predict the probability of Cingulate's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cingulate's price. Additionally, you may evaluate how the addition of Cingulate to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Transaction History
View history of all your transactions and understand their impact on performance